Tue, April 8, 2014
Mon, April 7, 2014
Fri, April 4, 2014
Thu, April 3, 2014
Wed, April 2, 2014
Tue, April 1, 2014
Mon, March 31, 2014
Fri, March 28, 2014
Thu, March 27, 2014
Wed, March 26, 2014
Tue, March 25, 2014
Mon, March 24, 2014

Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $70 on, Apr 1st, 2014

Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $60 to $70 on, Apr 1st, 2014.

Liav has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 3 agree with Liav's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Upgraded from Sell to Hold and Held Target at $49 on, Friday, March 14th, 2014
  • David Risinger of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $52 on, Friday, March 14th, 2014
  • Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014


This is the rating of the analyst that currently disagrees with Liav


  • Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014